These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8382981)

  • 1. Postmenopausal hormone replacement therapy.
    Clements D; Salter R
    BMJ; 1993 Jan; 306(6871):210. PubMed ID: 8382981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
    Lippert TH; Seeger H; Mueck AO
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of hormone replacement therapy to prevent postmenopausal osteoporosis.
    Dören M
    Osteoporos Int; 1999; 9 Suppl 2():S53-61. PubMed ID: 10525727
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of postmenopausal hormone replacement.
    Pearson Murphy BE
    JAMA; 2002 Dec; 288(22):2820; author reply 2823-4. PubMed ID: 12472320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New evidence of conjugated estrogen and 17beta-estradiol for treatment and prevention of osteoporosis].
    Kurabayashi T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():369-73. PubMed ID: 18161134
    [No Abstract]   [Full Text] [Related]  

  • 8. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women].
    Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K
    Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What you need to know: prescribing hormone replacement therapy.
    McCarthy TG
    Singapore Med J; 1997 Apr; 38(4):179-80. PubMed ID: 9269401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens and gestagens in the prevention of osteoporosis].
    Lauritzen C
    Zentralbl Gynakol; 1991; 113(8):475-8. PubMed ID: 1651636
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy: optimising the dose and route of administration.
    Montgomery Rice V
    Drugs Aging; 2002; 19(11):807-18. PubMed ID: 12428992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is 1 mg of estradiol valerate or 0.625 mg of conjugated estrogens sufficient for all women to prevent menopausal bone loss?
    Duursma SA; de Raadt M; Raymakers JA; Haspels AA
    Gynecol Endocrinol; 1992 Sep; 6(3):205-9. PubMed ID: 1332428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning and evening administration of hormone therapy in perimenopausal women.
    Pongsatha S; Chainual A; Morakote N
    Int J Gynaecol Obstet; 2005 Oct; 91(1):77-8. PubMed ID: 16122753
    [No Abstract]   [Full Text] [Related]  

  • 17. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen--no matter how delivered--relieves postmenopausal vasomotor symptoms.
    Bachmann G
    Menopause; 2003; 10(6):494-6. PubMed ID: 14627856
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose hormone replacement therapy: effects on bone.
    Gambacciani M; Monteleone P; Genazzani AR
    Climacteric; 2002 Jun; 5(2):135-9. PubMed ID: 12051108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.